Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Finland
Sweden
Denmark
Norway
Latest
Trending
Followed

Asker Healthcare, Audiocast, Q3'26

By Inderes11/4/2026, 9:00 AM
Asker Healthcare

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Johan Falk
00:01 - 03:47

Hello and welcome to the Asker Q3 2026 report presentation. We are happy to present a good and strong quarter, which feels very good. We have 24% adjusted EBITDA growth for the quarter, which we are very proud of. Net sales were 4.8 billion, and we are up 15%. More importantly, we achieved 5% organic growth, growing a bit faster than the market, which we promised to do and are seeing happen this quarter as well. So very good. The adjusted EBITDA of 473 million was up 24%, out of which 4% was organic. As you know, we are building a fantastic warehouse down in Gothenburg, and those costs were included in this quarter's result; if you take away the parallel distribution for the quarter, it would have been an 8% organic EBITA margin. Adjusted EBITDA margin for the quarter was 9.9%. The adjusted EBITDA margin was up to 9.9%, so 0.6 percentage points compared to last year. But maybe more importantly, for the first time in the last 12 months, we reached our target of 10% EBITA margin. Also up 0.6 percentage points from last year. So that's really, really good to see. The scale of the group and the efficiency gains we get from being the market leader are improving the EBITA margin quarter over quarter. So that's great. The cash flow was robust from operations. And given the capital-light business we have, our R/RK was 69% for the quarter, even though we welcomed new companies to the group. Our net debt over EBITDA was at 2.33, which is also well below the 2.5 which we promised to stay under. We welcome four new acquisitions this quarter, and we also have reached 100% of the acquisition target, which I'll come back to later in this presentation. Looking at the 12-month period, which I like to do, this is a steady, growing market where we improve our business in many dimensions and grow faster than the market on an LTM basis. We have 21% adjusted EBITA growth. However, R/RK is 69%. Also, in the longer perspective, it feels good to have reached the 10% EBITA margin target, which we have been aiming for. We came from 6% way back in time. And now we have improved in all lines on the P&L to reach 10%. So that's a little bit of internal celebration for us, and the 2.33 in leverage. This is the chart I internally use as well to make sure that whatever we do, we should improve. And customer satisfaction is number one, followed by organic growth, but also towards the market and our dear investors, we show that we are quarter by quarter having taller and taller bars on this chart. And this has been going on for many years, and I see no reason why it can't continue for many years as well. We have a fantastic pipeline of new companies that would like to come into the Asker family. And the market is growing steadily, organically. So hopefully we can continue this journey for a very long time. Over to you, Thomas.

Thomas Moss
03:48 - 15:26

Great. Thanks, Johan. Let's look in a little bit more detail at some of the numbers. If I start with the overview of the financial performance for the group. As Johan said, it was a good solid quarter for us both in terms of earnings and EBITDA. Net sales were up 15%, with 5% organic growth. We will dive more into the regions in a second, but you will see there is good revenue growth coming in North and the acquisitions contributing especially strongly in both West and Central. Adjusted EBITDA was up 24% in Q3, with 4% of that growth coming organically. As Johan mentioned, we have the one-off effects of the new DC operations, which are slightly dragging down the overall headline figures. Adjusted EBITDA margin at 9.9%, as Johan mentioned. I would also say we have spoken to quite a lot of you over the last few months, many analysts and investors. And there is a very detailed breakdown in note five at the back of our interim report. If you are interested in understanding the bridge to adjusted EBITDA. And then if we turn to the right-hand side of this chart, we can take a look at the nine-month perspective. And actually, we have had a very stable year. So Q1, Q2, and Q3, the trends that we have seen have very much played out through all three quarters. So 6% organic growth in EBITDA, 18% acquired growth, 23% total EBITDA growth with net sales organic growth at 5%. As Johan mentioned earlier, if I go into the regions in a little bit more detail, I will start with Business Area North. Also a good solid quarter, good to see organic revenue growth at 10%. Adjusted EBITDA in the quarter is down 7%. As I have mentioned before, and as Johan has mentioned, there is 16 million of additional costs due to the parallel operations. With the new distribution center impacting that figure. I have a slide on this in a second. I will talk a little bit more about the Gothenburg warehouse, so I will come back to that. Important to note that in Region North, we have the Nordic countries, as you can see in the little map there. So it tends to be our smallest region by far in volume terms. So small numbers can make quite a large difference to some of the percentages. But if you look on the right-hand side, I think the picture that we get from the nine-month year-to-date figures is a good representation of the region, solid sales growth and solid EBITDA growth at 4% as well. We don't often include exciting pictures in our presentations, but we couldn't resist it this time. This is the new distribution center down in Gothenburg. A super facility, state-of-the-art operations, and automation. We are extremely proud of it, and extremely proud of the team that has executed this so well, on time and on budget. And we are very much looking forward to the benefits that will flow through into the P&L and to the rest of the group that will come later in the year. But as I say, we don't often put pictures in, but this is something that we're extremely proud of. A couple more details on the distribution center. I am conscious that we have talked quite a lot about this over the last few quarters, and we have shared quite a lot of numbers. So it was a good opportunity just to collect all of those numbers in one page. So what you see here is the timeline along the top. And then the different aspects of financial impact that come from the new distribution center. I should note in italics, I have tried to put what we have said previously, so you can compare what we have delivered to what we have previously talked about. And as I said before, I think we are on track in terms of what we promised, what we have spent, and what we have delivered. So if you look in the middle of the chart there, under H2 2026, we have 30 million of Capex that has gone out. In Q3. We have another 40 million we are expecting to pay out in Q4. We had previously said that we expected to spend around 75 million of cash Capex in H2 2026. So we are in line with that. There is a little bit of further Capex that will go out in H1 2027. But you shouldn't misread that to imply that there's still major building activity or major installation activity going on in the warehouse. That is simply the time lag between installing the equipment, getting things up and running and tested. And then actually the invoices being paid. So net, we will be very much in line with the original communicated CapEx expectation of somewhere between 300 and 330 million SEK. And then as we move into H2 2027, we will see the group Capex drop back to that normal level that I've talked about before. Somewhere around 2% of sales for one-off costs. You see in the middle of the chart here, 16 million in Q3 that we've talked about, and we expect a similar amount to come in Q4 as we have this period of double operation of warehouses, ensuring everything is working and we are able to make sure that we don't let any of our customers down through this transition phase. Previously, I had talked about low tens of millions of SEK in H2. So again, in line with that communication, and then as we move into H1, there will be a small tail of further one-off costs, but smaller than either Q3 or Q4 on a standalone basis. And then potentially, as we move into 2027, there may be some small scrapping costs associated with old equipment in the old warehouses that is a little bit uncertain at the moment, because obviously you try to sell as much of that as possible, but be reassured that that is a non-cash item. We talked about needing around 100 million of extra working capital through the second half of 2026. That is what we see. That level has actually peaked now at the end of Q3; we expect to have that slightly elevated level of working capital through to the end of 2026. And then it will start to tail off relatively quickly as we move into the first part of 2027. Lease costs. The total operating cost of the facility is very similar to what it was in our previous facilities. So we swapped possibly even arguably three different facilities for a larger, more efficient, well-located facility, and the total cost to us on a running basis is the same as it was before. So we are happy about that. And then the EBITDA savings that will come through in the second half of 2027 will be between 50 and 60 million per year. And that is still very much in line with the original forecast. We gave a little bit more detail there, but hopefully you find that useful. As we have talked a lot about this. All right. I move forward to business area West. Which, as you will remember, has had very pleasing momentum all the way through 2026. We continue to see that in Q3, revenue growth up 11%, 3% organic growth and strong margin step up driving the adjusted EBITDA up 34% once you include the M&A as well. And there are a few different dynamics underlying that. One, of course, is something that I've talked about before: the strong performance of our home care hub in the Benelux region, an extremely strong operation where they continue to find operating efficiencies from that unit, which is a major contributor to the strong performance in West. But it is also important to note the M&A that we have brought in over the last few years into that hub, as well as into our Ireland and UK business. We did a good acquisition there with HSL. Eighteen months or so ago. They have in turn made acquisitions. And we are starting to see those scale benefits and cooperation between those companies. So we see a very pleasing performance in West. But I think I would just add a note of caution that the rate of increase in margin, you know, I think it's not reasonable to expect that to continue ever onwards. I think we will continue to drive margin upwards in West, but we might see a slightly slower rate of margin increase going forwards. Business area Central. Also, a nice strong quarter with the acquisitions continuing to be a key engine of the performance in Business Area Central. Net sales are up 32%. Organic revenue growth was 0%. I've talked about this before, but we continue to see that mix shift developing in Business Area Central, where we have been very focused on margin and efficiency. It has meant that we have walked away from some low margin revenues in some of our older units in Business Area Central, a move that we're happy with. We are happy to sacrifice some of that lower profitability revenue, and we see that come through strongly. The other point to obviously continue to note about Business Area Central is how successful we have been on the M&A agenda across the whole region. You have seen us acquire a number of very interesting units through the course of 2026, and we expect to continue to do that going forward. A brief look at our overall Q1 performance. This is a key internal metric. As I keep saying, the graph itself is perhaps not super exciting, but it shows us continuing to work with it, continuing to nudge in the right direction, focusing on margin and focusing on working capital. That is the thing that is delivering the cash to drive the M&A engine as we develop the business going forward; a word or two about cash flow. Also, we have a solid, robust view on the cash flow. It is important to remember what I mentioned about the temporary increase in working capital due to the double warehousing activities that we have going on in Gothenburg, which slightly impacts the headline figure. But it is completely in line with expectations, and Capex for the Gothenburg warehouse is also in line with expectations. Overall cash conversion is running exactly as we would want it to be. And we continue to have good visibility on future earn-outs coming in 2027, which are much lower than the earn-outs that we paid back in Q2 2026. If you remember, we paid more than 450 million out in Q2. And then one final page from me before I hand it back to Johan, a brief look at the leverage picture again, slightly down from Q2. We were sitting at 2.37 at the end of Q2. We have come down a little bit. But we are very confident in our ability to manage leverage and ensure that we have the capacity to continue to drive the M&A agenda as we choose to. I also include the alternative leverage ratio. I have mentioned this before. This is very much equivalent to the banking covenant definition where we include all of the earn-out debt. But I think also reasonably, we include the like-for-like effect. So we include the pro forma EBITDA of acquisitions. And that gives us a leverage of 2.41 according to that definition. And with that I hand back to Johan.

Johan Falk
15:27 - 20:50

Thanks, Thomas. Very good. Okay. Let's look into the second half and then the M&A agenda. This quarter. We have welcomed four new companies to the group. It was Murray Surgical in Ireland. Med Kjemi in Norway, as well as Labo Clinic and Ambercell Solutions in October, represent a total of 473 million. So it is a good addition to the group. Fantastic companies, good entrepreneurs in different disciplines. We also, after the quarter closed, welcomed Teresa in Estonia. So, a good quarter when it comes to M&A as well. And we have a very good pipeline. I am very happy to see that our strong market leader position makes us an attractive company to sell to, as families across Europe who want their businesses to continue and improve for a long time are turning to us. So that is, I am very proud to see the long line of good companies that we are hopefully welcoming over the years to come. And we have the bottom here, a little bit of a graph. We introduced this last time. We say that we have reached more than 100% of the yearly target. To explain what I mean, as you are well aware, a good serial acquirer has stable organic growth, using the cash flow to welcome new companies to the group. And that is what we call the twin engine. And for us to have a cash plan to buy 10 to 12% EBITDA growth every year, that is what we at least should do. And we are happy to see that we have reached that point. Now we have a quarter left, so we will not stop doing acquisitions, as you can imagine. But this is good to see. And I think it is a good way to measure. We remain disciplined on price. We have an average of 7x EBITDA that we pay for the different companies and use the cash to acquire new companies and see the growth coming. So that is a good sign and a good way to follow a serial acquirer, making sure that you have the cash to acquire new companies. So we reached that point now, which we are proud of. Looking into one of the acquisitions, we do roughly 10 to 15 acquisitions a year. It is hard to explain everyone in detail, but Murray Surgical is, as you know, a platform acquisition we bought in Ireland last year. HSL Group. So this is a very good addition to that fantastic company we have. They are a market leader and distributor of specialized surgical and medical products. And we see that they are adding roughly 73 million. And there are ninety employees in these niche segments that are complementing the HSL assortment in a very good way. Hopefully we can see some cross-selling as well across those companies. As with all the companies we have bought in the last few years, they will have a positive impact on our EBITDA margin as well. So that's good to see. So, if we are coming to an end before the Q&A session, just summarizing Q3, which we are proud to present with a 24% adjusted EBITDA growth, we have reached the 10% LTM margin, which is a bit of a victory for us to see that we are not only growing with acquisitions and having happy customers, but we are getting the efficiency out of the group, using the scale, and being able to increase the purchasing power across the group. And it translates into real numbers. And we have reached 100%, as I mentioned, of the M&A acquisition targets for the year. And with a very good pipeline and good visibility, we are now discussing the targets. The deals we will hopefully do next summer. So we have reached good momentum and are having discussions with roughly a couple of hundred different companies in our 19 countries. So there are broad distributed activities, and all the regions and all the different countries are doing an excellent job when it comes to keeping this momentum and going forward. The areas of focus continue to grow faster than the market organically, making sure that cash is always the focus to ensure we have enough capital, even in 2027, to achieve at least 10% to 12% growth, which we have maintained for many years, while broadening the product offering. We are serving millions of nurses and hundreds of thousands of doctors on a daily basis. And we want to be their number one partner to make healthcare more efficient across Europe. So that's something that is always priority number one for us. I think I'll stop there for this presentation and open up for questions.

Operator
20:53 - 21:11

If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial pound key six on your telephone keypad. The next question comes from Erik Cassel from Danske Bank. Please go ahead.

Erik Cassel
21:13 - 22:04

Hi. Good morning. I was going to ask about the acquired margins that we're seeing now. And I know you pushed back on this before, but what I'm seeing is that the acquisitions done this year are running close to 19% EBITDA margins since closing. And you show that in Note 4, 502 million in sales and 94 million in contribution to EBITDA. When I tried to square the performance numbers, it looks like they used to run at around 12% before that. And you said, I think in the last conference call, that it's accretive, but not very accretive. So I was just wondering about this 19% number. Do you think that these companies could sustainably hold that sort of high margin level, if this is correct, or do you think there are some temporary post-acquisition effects here that help the margins?

Thomas Moss
22:05 - 22:36

I can take that one. Eric. I think maybe we would have to have a quick look at the spreadsheet because, in all honesty, I don't recognize that 19% figure. Our view is that we bought good businesses this year. They are doing a good job in the niches that they are operating in. They are clearly margin enriching for the group as a whole. So, on average, I think the 12% that you quoted is much closer.

Erik Cassel
22:36 - 22:37

To what you are referring.

Thomas Moss
22:37 - 22:38

Show it.

Erik Cassel
22:38 - 22:55

You show it in note four. You show that the acquisitions year-to-date have added 94 million in contribution to reported numbers and 502 million to sales. I get that to 19% margin. So I was just wondering if there is anything special with it.

Thomas Moss
22:57 - 23:16

Let me come back to it. Eric. I need to try and understand the point that you're making there. I think we will probably not solve it here in this question. But in quick answer to your question, 19% is not a sustainable or underlying margin level for the M&A that we've done. No.

Erik Cassel
23:17 - 23:57

Okay. Perfect. Then I just have another question on the North region as well. If we exclude the temporary effects of having double warehousing, the North margin, I get it to 9.4% versus 9.9% a year ago. So it is still a bit worse despite the strong organic growth. So I am just wondering a bit about the drop-through on what is happening there. Where are you seeing those effects happen? How much of it is mix? Where do you see cost inflation? I guess any sort of color and explanation in more detail would be appreciated.

Thomas Moss
23:58 - 25:42

Yeah. No. And I think you're absolutely right. I recognize the 9.4 that you mentioned there, Eric. So yes, there is a small drop from Q3 2025 to Q3 2026 on the underlying margin in North, and I think Q3 is a small quarter for region North. So, relatively small absolute changes in numbers can have quite a large swing effect on the margins. So when I look at business area North as a whole, when we talk to the area managers, and when we look at the underlying operations, it is not as though we feel or see a fundamental underlying margin decline or big problems in that area. Definitely not. Actually, we see a very stable picture for operations in North. So I think partly those numbers, you have to look at them in a slightly longer context, given that Q3 is a small quarter for us. I think, and again, this is a little bit more anecdotal and I wouldn't want to try and put too much weight on this, but there is perhaps around the edges, around the margins, just in small numbers, a little bit of pressure from what I might call the Middle East Hormuz effect. We have seen a tiny bit of pressure in a couple of places on pricing. So there is a little bit there, but I don't think I would want to suddenly make a big deal of it and blame it on that. I think the effect that you see in the margin drop is much more driven by normal fluctuations and the fact that Q3 is a small quarter, and a few things falling one quarter or another can make quite a big difference to those percentages.

Erik Cassel
25:44 - 26:00

Okay, perfect. Thank you. And just the last question. You talked previously about Gothenburg costs being low. Tens of millions, 16 million. Now, do you expect them to come down to that sort of initial guidance, or should we, going forward, pencil in around the same level as we saw now?

Thomas Moss
26:01 - 26:22

What we said on that extra slide that I presented is we had 16 million in Q3, and Q4 will be similar to Q3. So, call it another 16 million. I do not know exactly how, but it will be in that range. So that would be 32 million in H2. And at least in my world, 32 million counts as low tens of millions.

Erik Cassel
26:25 - 26:26

Uh. Fair enough. Thank you.

Operator
26:30 - 26:42

As a reminder, if you wish to ask a question, please dial pound key five on your telephone keypad. The next question comes from Jakob Lemke from SEB. Please go ahead.

Jakob Lemke
26:45 - 27:10

Yes. Good morning. My first question is also on North. I struggle a bit to really understand the development here. I mean, it is actually the second quarter here where we have quite strong top line growth. But we struggle with modern developments. So can you elaborate a bit more on how top line growth can be so strong while margins remain quite weak?

Thomas Moss
27:13 - 27:29

Yeah. I am not sure, Jakob, that I can add much to the answer I just gave to Erik on that. I think we are comfortable and confident in the underlying performance in North. There are some. There are some natural fluctuations. I do not know, Johan. Maybe you want to add a word or two.

Johan Falk
27:30 - 29:33

I think for those of you who have followed big industrial projects, this is one of them. Of the projects that take like three years from the PowerPoint to completion. It is fully functional. It is impossible. On a quarterly basis, it is difficult to see exactly which costs go into which line and at what time. This is a big impact. This is a big project that kind of impacts the whole group. We are on time, we are on budget, and we will see the 50 to 60 million net profit increase when the project is fully operational. Second half of next year. So, we feel comfortable with that. But it of course affects the whole group. When you are moving. A lot of. I think they delivered 20,000 boxes per day. You can just imagine the change. And since I'm a bit. I am a bit extreme in this regard and I want full redundancy. I want to make sure that we have our old warehouse fully functioning, and at the same time, as we build up the new one, we do not. So we do not disappoint any nurses and doctors by failing to deliver during these three years; you have, of course, some extra cost and some small troubles that you need to fix. So I think we need to take a step back and look at the totality. It is roughly 350 million in investments. It will take a couple of years to make it happen. And we still are focused on this 50-60 million that will give us profit during this time of a little bit extra working capital and cost. It can, of course, influence the quarter-by-quarter comparison, especially when you have a smaller quarter, as it impacts the overall results. So I think that is a good answer. Top line growth is the most robust thing we have. When you are selling thousands and thousands of supplies, devices, and equipment to the Nordic hospitals and healthcare centers. That is what matters and that is what counts. And I think you should not be worried about this underlying stability of operations in the Nordics.

Jakob Lemke
29:37 - 29:56

Okay. But then on the top-line component, I mean, two quarters now in a row with 10% organic growth. And then it was, I think, 7% in Q1. So, what is driving that strong growth? Is there any specific product area or subsidiary that you can elaborate on?

Thomas Moss
29:59 - 31:18

I think maybe I should switch it and say that we are not looking at a situation where we had one big one-off project. If you go back to 2024, we had the effect of the GDP helping the result. So it is a broad-based picture. The underlying operations are good. We are finding new customers, we are finding new channels, and we are finding efficiencies in our operations. It is a genuinely broad-based effect, but I think as we are keen to emphasize and Johan is keen to emphasize, you should not read too much into either very strong growth or very weak growth in any individual quarter. Fundamentally, it's a very stable market out there. We will consistently do a little bit better than the market over time. But I wouldn't be building 9% or 10% organic revenue growth into my model for the Nordics going forward. We have had a couple of good quarters. And the business is doing well. The teams out there have done a good job to deliver that, but that is clearly not a long-term sustainable trend. It will revert to the kind of 5-6% growth rate that we are targeting across the group as a whole.

Johan Falk
31:19 - 32:07

Yeah. As I mentioned on my second slide, we saw 21% adjusted EBITDA growth on a rolling 12-month basis. And for those of you who have followed us for a number of years, you know that we have been delivering those kind of growth numbers for a very long time. And if you divide that up, it is faster than market growth organically. Five to 6%, sometimes even more. And then organic and additional M&A growth. So looking at these specific quarters and a specific country or region, it can differ a little bit, but there is usually a good explanation underneath. So hopefully that is a good explanation. Hopefully that answers your question.

Jakob Lemke
32:09 - 32:30

I understand. Then on West and Central. I am wondering first if you have any sort of one-time benefit on earnings in this quarter from currency revaluation of operating receivables and liabilities. I think you had some 15 million in positive other income in the income statement, for example.

Thomas Moss
32:33 - 32:46

No, I don't think so; I think what you see on the picture for those is a fair underlying reflection of the organic performance of those businesses.

Jakob Lemke
32:51 - 33:16

Okay. Then on West, I think you gave good color here on the call regarding what is driving the good earnings growth. Given that it sounds to be quite efficiency-driven, should we read that as you have achieved a higher level you're now operating at, and that we can assume at least the margins you're doing now can be sustained going forward?

Thomas Moss
33:16 - 33:50

Yes, I believe so. Yeah. No, I think that's important. And I really want to emphasize this. So we see the margins that we are reaching in West as being sustainable. The comment I gave was very much about the rate of increase that will probably slow. So we have, in a sense, stepped up to a new baseline and we will continue to improve from that new baseline. But I don't think you can expect us to sustainably maintain this rate of increase. The rate of increase will slow a little.

Jakob Lemke
33:53 - 34:05

And then maybe finally on M&A, I mean, you have maintained a quite good pace since the summer, I would say. Do you still see that you have a pipeline and can sustain this pace in the coming six months?

Johan Falk
34:06 - 35:23

Yes, absolutely. I think we can say that we have reached the position we want to be in. We have roughly two years of visibility on around 200 contacts in this. Our 19 markets, with which we are having a dialogue. And then we slowly but steadily are getting to know these companies. And when they are ready and we are ready, we have a bilateral discussion and they are happy to come to us. And we were happy to acquire them after, of course, due diligence and all of that. So we have no problem finding good companies to invest our cash flow. Going forward. Right now, I think the pipeline is almost full to next summer, and it's more of a matter of who we should welcome first than having a problem finding anyone. But having said that, we will remain disciplined around pricing. So seven times is kind of the average. I think we are a bit below that right now. And then also being disciplined on leverage, making sure that we use our own generated cash as we welcome new companies. So good visibility. Yes.

Jakob Lemke
35:26 - 35:28

Sounds good. That is all for me today. Thank you.

Johan Falk
35:29 - 35:30

Thank you very much.

Operator
35:32 - 35:37

The next question comes from Gustaf from Nordea. Please go ahead.

Gustaf
35:38 - 36:07

Yes. Good morning. It is Gustav from Nordea. I thought we could just come back slightly to the North. Just in terms of a scenario. Thomas, you highlighted that there could be some pressure from raw material price increases, etc. But just to get your sense of, are you able to implement price increases to offset this, or are you doing that right now as well? And how fast can this sort of increase be pushed through in such a scenario?

Thomas Moss
36:09 - 37:37

Yeah. I will try to answer that at a high level. It obviously varies between countries, between customers, and between products. But broadly speaking, big picture and longer term, we actually find that we are not a business that gets squeezed in the middle. We have a lot of experience with that. Even if you go back to the Covid times with us being between the healthcare system and the OEMs, we have generally over time been very successful at pushing price increases through to our customers or resisting price increases from the OEMs. So it is not as though we sit in a system where we are the one who is vulnerable and needs to absorb the ebbs and flows of what comes down the value chain towards us. Having said that, there will always be some cases of certain customers or certain products where it takes longer to get the price increase through, or we have to look for a different source of product. So there are smaller short-term fluctuations. I think we are probably seeing just a little bit of that in North at the moment. But the big picture longer term, the structural strength of the position that we now find ourselves in, the good relationships that we have with our customers and the good relationships that we have with our OEMs mean that we are very secure, that we are not the one who gets squeezed in these situations.

Gustaf
37:40 - 37:54

That is helpful. Just to clarify, there are no sort of extraordinary price increases that we are seeing now, in the last couple of quarters in Q3, and nothing that sticks out going forward.

Thomas Moss
37:54 - 38:09

No, these are small effects around the edges on occasional customers or occasional products or categories. There is no large systemic challenge that we need to address now.

Gustaf
38:11 - 38:37

Oh, perfect. And then on Central, I mean a clear focus on profitability, for sure. I mean, and of course, quite limited top-line growth, at least organically. How should we think here going forward? Should we expect you to focus on driving organic sales growth in the coming quarters? Now for Central, how should we think?

Johan Falk
38:38 - 40:01

Yeah. I think, first and most importantly, the basics of the growth is, of course, the market itself. And there is no difference in the DACH region or Poland, Czech Republic, and the markets that summarize the Central region compared to West or North. We are serving as many hospitals in different countries and we have the same needs. So 3% to 4% market growth is what you should expect from the market over the long term. And since we are buying top companies in each segment, we should perform a little bit better than the market. I can assure you that the fantastic team in Central has integrated many market-leading niche companies that are performing significantly better than what you see in this total sum of zero. So you should expect, and I am expecting, faster than market growth in Central going forward, but exactly how long will it take to clean out these low-margin products and so on? I won't promise faster than market growth for the next quarter, but that is absolutely nothing to worry about in the medium to long term. They are doing a great job welcoming companies that are growing faster than the market. So Central should grow faster than the market in the medium to long term. Absolutely.

Thomas Moss
40:01 - 40:42

Yeah. It's a little bit the same message that we've given for the other regions where over time, they will all come back to this sort of core fundamental performance as Johan describes. So, in Central, we would expect the rate of margin increase to slow, and we would expect the rate of organic revenue growth to increase again as they come back to the core fundamentals that we seek when buying businesses that are better than the average. And we add the Asker Healthcare Group benefit on top of that, which means that we get some leverage down to margin as well. Um, yeah.

Gustaf
40:45 - 40:59

No, that is very helpful. And then just a final one, if we look at the P&L, I mean, the financial income and expenses, seemingly very low in the quarter. Is there anything to consider going forward there?

Thomas Moss
41:00 - 41:36

No, I think that, of course, it also fluctuates a little bit with FX rates and those sorts of things. That is the only thing that drives those fluctuations. So I think that one, you have to be aware that we don't do anything clever or complicated with our funding structure. We are not engaging in exotic financial instruments or anything like that. So again, this is something that should always revert to the mean. And certainly from a modeling perspective, I would always put the long-term average in for those lines and see that going forward, there is no fundamental structural change in anything that we're doing down there.

Gustaf
41:39 - 41:41

That is very clear. Thank you very much.

Thomas Moss
41:42 - 41:42

Thanks, Gustav.

Operator
41:45 - 41:51

There are no more questions at this time. So I hand the conference back to the speakers for any closing comments.

Johan Falk
41:53 - 42:00

Okay. Thank you for the good questions. And thank you for listening and see you again in the next quarter. Thank you and goodbye.

Continue to the webcast
Revenio Group Oyj, Q3'26
Language: English11/12/2026, 1:00 PM
Jukka Kainulainen Good afternoon, and welcome to the Revenio Group Corporation Q3 Earnings Call. My name is Jouni Toijala. I am the CEO. And then, again today we have Jukka Kainulainen, our CFO, on th…
Kamux, Q3'26
Language: English11/12/2026, 9:00 AM
Katerina Heterant Good morning. Welcome to the Kamux Q3 results presentation. My name is Katerina Heterant and I am Head of Investor Relations at Kamux. Today we shall go through the Q3 results presen…
Koskisen, Webcast, Q3'26
Language: Finnish11/12/2026, 8:00 AM
Jukka Pahta Hyvää huomenta ja tervetuloa tähän osavuosikatsaustilaisuuteen! Koskisen tammi–syyskuun osavuosikatsaustilaisuuteen lähdetään otsikolla: Koskisen liikevaihdon kasvu jatkui. Kohonneet kusta…
Reaktor, Q3'26
Language: Finnish11/11/2026, 9:00 AM
Pekka Horo Oikein hyvää aamupäivää kaikille ja tervetuloa tähän meidän webcastiimme. Olen Pekka Horo, Reaktorin toimitusjohtaja, ja kanssani täällä on tänään Antti Akkanen, joka aloitti lokakuussa Rea…
Savox, Q3'26
Language: English11/10/2026, 11:00 AM
Paulina Tanila Our speakers today are CEO Jerry Kettunen and CFO Juha Järvi. Jerry will give an overview of Savox as a company and go through the highlights of the quarter. After that, Juha will conti…
Raisio Oyj, Webcast, Q3'26
Language: Finnish11/10/2026, 10:00 AM
Elli Siltala Hyvää marraskuista päivää Raisiosta! Ja tervetuloa Raision tammi-syyskuun 2026 osavuosikatsauksen webcastiin! Pahoittelut pienistä teknisistä haasteista, mitä meillä oli tässä alussa. Min…
Mandatum Oyj, Audiocast, Q3'26
Language: English11/10/2026, 9:00 AM
Lotta Borgström Good morning, everyone, and welcome to the Mandatum Q3 2026 audiocast. My name is Lotta Borgström from Investor Relations. Joining me today are our CEO, Petri Niemisvirta, and our CFO,…
Solar foods Go-to-market Update
Language: English11/9/2026, 12:00 PM
Maria Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli…
Outokumpu, Webcast, Q3'26
Language: English11/6/2026, 12:30 PM
Johan Welcome to the third quarter results webcast. I am responsible for investor relations. We will start with the presentation from our CEO, Kati ter Horst, and our CFO, Marc-Simon Schaar. After the…
Endomines, Webcast, Q3'26
Language: English11/5/2026, 1:00 PM
Andy Turpin Hello, everyone, and welcome to Endomines' third-quarter results webcast. Thanks for joining us today. My name is Andy Turpin and I am the Chief Communications Officer here at Endomines. A…
Lemonsoft Oyj, Q3'26 webcast
Language: English11/5/2026, 11:00 AM
Unknown 1 Welcome to the Lemonsoft Q3 results presentation. We will start with the presentation from CEO Alpo Luostarinen, followed by the Q&A. You can send your questions throughout the event via the…
Enersense, Webcast, Q3'26
Language: English11/5/2026, 10:30 AM
Liisa Tamminen Hello and welcome to the Enersense Q3 2026 results webcast. My name is Liisa Tamminen from Enersense Investor Relations. And with me here I have our CEO, Kari Sundbäck, and CFO, Jan-Elo…
Sitowise, Q3'26
Language: English11/5/2026, 10:00 AM
Mari Reponen Good day everyone, and welcome to the Sitowise Q3 2026 results audiocast. My name is Mari Reponen, and I am responsible for strategy and IR here at Sitowise. And today with me are our act…
Orthex, Webcast, Q3'26
Language: English11/5/2026, 9:00 AM
Alexander Rosenlew Good morning and welcome to the Orthex Interim Report. My name is Alexander Rosenlew and with me I have Saara Mäkelä, CFO, and Hanna Kukkonen, our CMSO. We will take you through the…
Suominen Oyj, Q3'26
Language: English11/5/2026, 8:30 AM
Anni Luoma Good morning, everyone, and welcome to the Suominen Q3 webcast. My name is Anni Luoma. I am the Manager of External Communications and Investor Relations at Suominen. Here with me are our P…
Lumo, Webcast, Q3'26
Language: English11/5/2026, 8:00 AM
Niina Saarto Good morning, all. Welcome. This is Lumo Homes plc's third quarter result webcast. I am Niina Saarto from Treasury and Investor Relations. Today I have two gentlemen here with me, namely…
CapMan, Webcast, Q3'26
Language: English11/5/2026, 7:30 AM
Charlotte Good morning and welcome to this presentation of CapMan. Q3 2026 interim report. Presenting today we have Pia Kåll, CEO of CapMan. And after the presentation, we will have a Q&A session. You…
Marimekko, Webcast, Q3'26
Language: English11/4/2026, 12:00 PM
Anna Good afternoon. My name is Anna and I am the IRO of Marimekko. It is my pleasure to welcome you to our Q3 webcast. With me, I have our president and CEO, Tiina Alahuhta, who will walk you through…
Administer, Webcast, Q3'26
Language: Finnish11/4/2026, 9:00 AM
Kimmo Herranen Welcome to the Administer Q3 2026 interim report. Results. Meillä on se alkaa. I am Kimmo Herranen. Kalle Lehtonen. Also. Kaarina og. Yelken. Kalle Lehtonen En el coco. Madan. Parannus.…
Kempower, Webcast, Q3'26
Language: English11/4/2026, 8:30 AM
Unknown 1 Powering the planet. Kempower. We charge our planet for the better. By powering the electric movement. We enable quick and scalable EV charging solutions for everyone and everywhere. We ma…